IllnessAnophthalmia, microphthalmia: differential diagnosis
Summary
Comprehensive differential diagnostic panel for Anophthalmia/ Microphthalmia comprising 17 or 56 curated genes according to the clinical signs
Loci type | Count |
---|---|
Gen | 55 |
156,9 kb (Extended panel: incl. additional genes)
- EDTA-anticoagulated blood (3-5 ml)
NGS +
[Sanger]
Loci panel
Gen
Name | Exon Length (bp) | OMIM-G | Referenz-Seq. | Heredity |
---|---|---|---|---|
ALDH1A3 | 1539 | NM_000693.4 | AR | |
BCOR | 5166 | NM_017745.6 | XL | |
BMP4 | 1227 | NM_001202.6 | AD | |
FOXE3 | 960 | NM_012186.3 | AR | |
GDF3 | 1095 | NM_020634.3 | AD | |
GDF6 | 1368 | NM_001001557.4 | AD | |
HCCS | 807 | NM_005333.5 | XL | |
MFRP | 1740 | NM_031433.4 | AR | |
OTX2 | 870 | NM_172337.3 | AD | |
PAX6 | 1269 | NM_000280.5 | AD | |
RAX | 1041 | NM_013435.3 | AR | |
SHH | 1389 | NM_000193.4 | AD | |
SIX6 | 741 | NM_007374.3 | AR | |
SMOC1 | 1308 | NM_001034852.3 | AR | |
SOX2 | 954 | NM_003106.4 | AD | |
STRA6 | 2004 | NM_001142617.2 | AR | |
VSX2 | 1086 | NM_182894.3 | AR | |
ABCB6 | 2529 | NM_005689.4 | AD | |
ATOH7 | 459 | NM_145178.4 | AR | |
BMP7 | 1296 | NM_001719.3 | AD | |
C12orf57 | 381 | NM_138425.4 | AR | |
CHD7 | 8994 | NM_017780.4 | AD | |
COL4A1 | 5010 | NM_001845.6 | AD, Mult | |
CRYBA4 | 591 | NM_001886.3 | AD | |
FAT1 | 13767 | NM_005245.4 | AR | |
FOXC1 | 1662 | NM_001453.3 | AD | |
FRAS1 | 12039 | NM_025074.7 | AR | |
FREM1 | 6540 | NM_144966.7 | AR | |
FREM2 | 9510 | NM_207361.6 | AR | |
GRIP1 | 3231 | NM_021150.4 | AR | |
HESX1 | 558 | NM_003865.3 | AD, AR | |
HMGB3 | 603 | NM_005342.4 | XL | |
KMT2D | 16614 | NM_003482.4 | AD | |
MAB21L2 | 1080 | NM_006439.5 | AD, AR | |
MYRF | 3506 | NM_001127392.3 | AD | |
NAA10 | 663 | NM_001256119.2 | XL | |
NHS | 4425 | NM_001136024.4 | XL | |
PAX2 | 1254 | NM_003987.5 | AD | |
PITX2 | 816 | NM_153427.2 | AD | |
PORCN | 1386 | NM_203475.3 | XL | |
PQBP1 | 798 | NM_005710.2 | XLR | |
PRSS56 | 1812 | NM_001195129.2 | AR | |
PXDN | 4440 | NM_012293.3 | AR | |
RAB18 | 621 | NM_021252.5 | AR | |
RAB3GAP1 | 2946 | NM_012233.3 | AR | |
RAB3GAP2 | 4182 | NM_012414.4 | AR | |
RARB | 1347 | NM_000965.5 | AD, AR | |
SALL2 | 3024 | NM_005407.3 | AR | |
SMO | 2364 | NM_005631.5 | AD | |
TBC1D20 | 1212 | NM_144628.4 | AR | |
TENM3 | 8100 | NM_001080477.4 | AR | |
TFAP2A | 1296 | NM_001032280.3 | AD | |
TMEM98 | 681 | NM_001033504.2 | AD | |
VAX1 | 1005 | NM_001112704.2 | AR | |
YAP1 | 1515 | NM_001130145.3 | AD |
Informations about the disease
Group of disorders: Microphthalmia-anophthalmia-coloboma
ORPHA:1104 Anophthalmia plus syndrome
ORPHA:91129 Anophthalmia-heart and pulmonary anomalies-intellectual disability syndrome Keyword: Anophthalmia-heart and pulmonary anomalies-mental retardation syndr.
ORPHA:1102 Anophthalmia-hypothalamo-pituitary insufficiency syndrome
ORPHA:1101 Anophthalmia-megalocornea-cardiopathy-skeletal anomalies syndrome
ORPHA:77298 Anophthalmia/microphthalmia-esophageal atresia syndrome
ORPHA:98938 Colobomatous microphthalmia Synonym: Microphthalmia-anophthalmia-coloboma syndrome
ORPHA:2542 Isolated microphthalmia-anophthalmia-coloboma Synonym: Isolated anophthalmia-microphthalmia syndrome Keyword(s) : Primitive anophthalmia ; Microphthalmia-anophthalmia-coloboma spectrum
ORPHA:2470 Matthew-Wood syndrome Synonym: Anophthalmia-pulmonary hypoplasia syndrome
ORPHA:1106 Microphthalmia with limb anomalies Synonym: Waardenburg anophthalmia syndrome
ORPHA:98555 Microphthalmia-anophthalmia-coloboma Synonym: Anophthalmia-microphthalmia syndrome Keyword: Microphthalmia-anophthalmia-coloboma spectrum
ORPHA:35612 Nanophthalmos Synonym: Nanophthalmia
ORPHA:178364 Syndromic microphthalmia type 5 Synonym: Syndromic microphthalmia/anophthalmia due to OTX2 mutation
ORPHA:202948 Syndromic microphthalmia-anophthalmia-coloboma Keyword: Microphthalmia-anophthalmia-coloboma spectrum
- Alias: Anophthalmia-microphthalmia syndrome
- Alias: Anophthalmos, microphthalmos
- Alias: Microphthalmia-anophthalmia-coloboma
- Allelic: Aniridia (PAX6)
- Allelic: Aortic aneurysm, familial thoracic 11, susceptibility to (FOXE3)
- Allelic: Basal cell nevus syndrome (PTCH1)
- Allelic: Bifid nose with/-out anorectal + renal anomalies (FREM1)
- Allelic: CHARGE [Coloboma, Heart anom., choanal Atresia, Retard., Genital/Ear anom.] syndrome (CHD7)
- Allelic: Cardiac-urogenital syndrome (MYRF)
- Allelic: Cataract 34, multiple type (FOXE3)
- Allelic: Cataract 40, XL (NHS)
- Allelic: Cataract with late-onset corneal dystrophy (PAX6)
- Allelic: Coloboma of optic nerve (PAX6)
- Allelic: Coloboma, ocular (PAX6)
- Allelic: Encephalitis/encephalopathy, mild, reversible myelin vacuolization (MYRF)
- Allelic: Facioscapulohumeral muscular dystrophy 2, digenic (SMCHD1)
- Allelic: Foveal hypoplasia 1 (PAX6)
- Allelic: Glomerulosclerosis, focal segmental, 7 (PAX2)
- Allelic: Growth hormone deficiency with pituitary anomalies (HESX1)
- Allelic: Holoprosencephaly 3 (SHH)
- Allelic: Hypogonadotropic hypogonadism 5 with/-out anosmia (CHD7)
- Allelic: Keratitis (PAX6)
- Allelic: Klippel-Feil syndrome 1, AD (GDF6)
- Allelic: Klippel-Feil syndrome 3, AD (GDF3)
- Allelic: Leber congenital amaurosis 17 (GDF6)
- Allelic: Linear skin defects with multiple congenital anomalies 1 (HCCS)
- Allelic: Morning glory disc anomaly (PAX6)
- Allelic: Multiple synostoses syndrome 4 (GDF6)
- Allelic: Nance-Horan [cataract-dental] syndrome (NHS)
- Allelic: Ogden syndrome [growth failure, delayed psychomotor development, dysmorphisms] (NAA10)
- Allelic: Optic disc anomalies with retinal and/or macular dystrophy (SIX6)
- Allelic: Optic nerve hypoplasia (PAX6)
- Allelic: Pallister-Hall-like syndrome (SMO)
- Allelic: Persistent hyperplastic primary vitreous, AR (ATOH7)
- Allelic: Pituitary hormone deficiency, combined, 5 (HESX1)
- Allelic: Pituitary hormone deficiency, combined, 6 (OTX2)
- Allelic: Retinal dystrophy, early-onset, with/-out pituitary dysfunction (OTX2)
- Allelic: Ring dermoid of cornea (PITX2)
- Allelic: Schizencephaly (SHH)
- Allelic: Single median maxillary central incisor (SHH)
- Allelic: Temtamy syndrome [Ment. retard., craniofacial dysmorph., coloboma] (C13orf57)
- Allelic: Trigonocephaly 2 (FREM1)
- Anophthalmia (PAX6)
- Anophthalmia, microphthalmia (RAX, SIX6)
- Anterior segment dysgenesis 2, multiple subtypes (FOXE3)
- Anterior segment dysgenesis 3, multiple subtypes (FOXC1)
- Anterior segment dysgenesis 4 (PITX2)
- Anterior segment dysgenesis 5, multiple subtypes (PAX6)
- Anterior segment dysgenesis 7, with sclerocornea (PXDN)
- Axenfeld-Rieger syndrome, type 1 (PITX2)
- Axenfeld-Rieger syndrome, type 3 (FOXC1)
- BMP4-Related Syndromic Microphthalmia (BMP4)
- Bilateral microphthalmia, short stature + facial dysmorphism [panelapp] (OLFM2)
- Bosma arhinia microphthalmia syndrome (SMCHD1)
- Branchiooculofacial syndrome (TFAP2A)
- Cataract 9, multiple types (CRYAA)
- Cerebrooculofacioskeletal syndrome 4 (ERCC1)
- Coloboma, ocular, AR (SALL2)
- Coloboma, ocular, with/-out hearing impairment, cleft lip/palate, mental retardation (YAP1)
- Colobomatous microphthalmia [panelapp] (FAT1)
- Curry-Jones syndrome, somatic mosaic (SMO)
- Focal dermal hypoplasia (PORCN)
- Fraser syndrome 3 [cryptophthalmus + other malformations] (GRIP1)
- Fraser syndrome [cryptophthalmus + other malformations] (FRAS1)
- Holoprosencephaly 7 (PTCH1)
- Isolated Microphthalmia (MFRP)
- Joubert syndrome 22 (PDE6D)
- Kabuki syndrome 1 (KMT2D)
- Manitoba oculotrichoanal syndrome (FREM1)
- Martsolf [cataract-mental retardation-hypogonadism] syndrome (RAB3GAP2)
- Microphthalmia with cataract 2 (SIX6)
- Microphthalmia with coloboma 3 (VSX2)
- Microphthalmia with coloboma 5 (SHH)
- Microphthalmia with coloboma 6 (GDF3)
- Microphthalmia with coloboma 6, digenic (GDF6)
- Microphthalmia with limb anomalies (SMOC1)
- Microphthalmia, Kabuki syndrome 1 (KMT2D)
- Microphthalmia, coloboma, micrognathia, diaphragmatic hernia [panelapp] (TMX3)
- Microphthalmia, isolated 2 (VSX2)
- Microphthalmia, isolated 3 (RAX)
- Microphthalmia, isolated 4 (GDF6)
- Microphthalmia, isolated 5 (MFRP)
- Microphthalmia, isolated 6 (PRSS56)
- Microphthalmia, isolated 7 (GDF3)
- Microphthalmia, isolated 8 (ALDH1A3)
- Microphthalmia, isolated, with coloboma 7 (ABCB6)
- Microphthalmia, isolated, with coloboma 8 (STRA6)
- Microphthalmia, isolated, with coloboma 9 (TENM3)
- Microphthalmia, syndromic 1 (NAA10)
- Microphthalmia, syndromic 11 (VAX1)
- Microphthalmia, syndromic 13 (HMGB3)
- Microphthalmia, syndromic 14 (MAB21L2)
- Microphthalmia, syndromic 15 (TENM3)
- Microphthalmia, syndromic 2 (BCOR)
- Microphthalmia, syndromic 3 (SOX2)
- Microphthalmia, syndromic 5 (OTX2)
- Microphthalmia, syndromic 6 (BMP4)
- Microphthalmia, syndromic 7 (HCCS)
- Microphthalmia, syndromic 9 (STRA6)
- Microphthalmia/coloboma + skeletal dysplasia syndrome (MAB21L2)
- Nanophthalmos 2 (NFRP)
- Nanophthalmos 4 (TMEM98)
- Nanophthalmos [panelapp] (MYRF)
- Nanophthalmos, high hyperopia (MYRF)
- OTX2-related syndromic microphthalmia 4 (OTX2)
- Oculogastrointestinal neurodevelopmental syndrome (CAPN15)
- Optic nerve hypoplasia and abnormalities of the central nervous system (SOX2)
- Orofaciodigital syndrome IX [panelapp] (SCLT1)
- Papillorenal [renal coloboma] syndrome (PAX2)
- Renpenning [mental retardation, XL syndromic] syndrome (PQBP1)
- Septooptic dysplasia [optic nerve hypopl., pituitary hypoplasia, midline brain anomalies] (HESX1)
- Warburg micro syndrome 1 (RAB3GAP1)
- Warburg micro syndrome 12 (RARB)
- Warburg micro syndrome 2 (RAB3GAP2)
- Warburg micro syndrome 3 (RAB18)
- Warburg micro syndrome 4 (TBC1D20)
- AD
- AR
- Mult
- XL
- XLR
- Multiple OMIM-Ps
Bioinformatics and clinical interpretation
Test-Stärken
- DAkkS-akkreditiertes Labor
- EU-Richtlinie für IVD in Umsetzung
- Qualitäts-kontrolliert arbeitendes Personal
- Leistungsstarke Sequenzierungstechnologien, fortschrittliche Target-Anreicherungsmethoden und Präzisions-Bioinformatik-Pipelines sorgen für überragende analytische Leistung
- Sorgfältige Kuratierung klinisch relevanter und wissenschaftlich begründeter Gen-Panels
- eine Vielzahl nicht Protein-kodierender Varianten, die in unseren klinischen NGS-Tests mit erfasst werden
- unser strenges Variantenklassifizierungsschema nach ACMG-Kriterien
- unser systematischer klinischer Interpretations-Workflow mit proprietärer Software ermöglicht die genaue und nachvollziehbare Verarbeitung von NGS-Daten
- unsere umfassenden klinischen Aussagen
Testeinschränkungen
- Gene mit eingeschränkter Abdeckung werden gekennzeichnet
- Gene mit kompletten oder partiellen Duplikationen werden gekennzeichnet
- es wird angenommen, dass ein Gen suboptimal abgedeckt ist, wenn >90% der Nukleotide des Gens bei einem Mapping-Qualitätsfaktor von >20 (MQ>20) nicht abgedeckt sind
- die Sensitivität der Diagnostik zur Erkennung von Varianten mit genannten Testeinschränkungen ist möglicherweise begrenzt bei:
- Gen-Konversionen
- komplexe Inversionen
- Balancierte Translokationen
- Mitochondriale Varianten
- Repeat-Expansionen, sofern nicht anders dokumentiert
- nicht kodierende Varianten, die Krankheiten verursachen, die von diesem Panel nicht mit abgedeckt werden
- niedriger Mosaik-Status
- Repeat-Blöcke von Mononukleotiden
- Indels >50bp (Insertionen-Deletionen)
- Deletionen oder Duplikationen einzelner Exons
- Varianten innerhalb von Pseudogenen
- die analytische Sensitivität kann geringer ausfallen werden, wenn die DNA nicht von amedes genetics extrahiert wurde
Laboratory requirement
Die in grün gezeigten Gene sind kuratiert und werden als Gen-Panel untersucht. Eine Erweiterung des Panels (blau gezeigte Gene, jeweils ebenfalls kuratiert) kann auf Anfrage erfolgen. Sofern unter "Erweitertes Panel" ein Minuszeichen angezeigt wird, sind nur Core-/Basis-Gene verfügbar.
Für die Anforderung einer genetischen Untersuchung senden Sie uns bitte die Krankheits-ID auf einem Überweisungsschein. Bitte die Material-Angabe beachten.
Für privat versicherte Patienten empfehlen wir einen Antrag auf Kostenübernahme bei der Krankenversicherung.
Die Untersuchung wird auch für Selbstzahler angeboten.